The Endocannabinoid System: Drug Targets, Lead Compounds, and Potential Therapeutic Applications
Top Cited Papers
- 19 July 2005
- journal article
- review article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 48 (16) , 5059-5087
- https://doi.org/10.1021/jm058183t
Abstract
No abstract availableThis publication has 298 references indexed in Scilit:
- Phylogenomic and chemotaxonomic analysis of the endocannabinoid systemBrain Research Reviews, 2004
- N-Cyclohexanecarbonylpentadecylamine: a selective inhibitor of the acid amidase hydrolysing N-acylethanolamines, as a tool to distinguish acid amidase from fatty acid amide hydrolaseBiochemical Journal, 2004
- Plant-derived, synthetic and endogenous cannabinoids as neuroprotective agentsBrain Research Reviews, 2003
- Despite substantial degradation, 2‐arachidonoylglycerol is a potent full efficacy agonist mediating CB1 receptor‐dependent G‐protein activation in rat cerebellar membranesBritish Journal of Pharmacology, 2001
- Highly Selective CB1 Cannabinoid Receptor Ligands and Novel CB1/VR1 Vanilloid Receptor “Hybrid” LigandsBiochemical and Biophysical Research Communications, 2001
- Arachidonoylserotonin and Other Novel Inhibitors of Fatty Acid Amide HydrolaseBiochemical and Biophysical Research Communications, 1998
- Novel Inhibitors of Brain, Neuronal, and Basophilic Anandamide AmidohydrolaseBiochemical and Biophysical Research Communications, 1997
- Fatty Acid Sulfonyl Fluorides Inhibit Anandamide Metabolism and Bind to the Cannabinoid ReceptorBiochemical and Biophysical Research Communications, 1997
- Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compoundsLife Sciences, 1984
- The Preparation and Properties of 3(α),11-Dihydroxy-12-ketocholanic AcidJournal of the American Chemical Society, 1940